Molecular cytogenetic quantitation of gains and losses of genetic material from human gliomas

Burt G.F. Feuerstein, Gayatry Mohapatra

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The unregulated growth that is characteristic of human malignant gliomas is accompanied by, and may result from, losses and/or gains of genetic material. Understanding the mechanisms that underlie how particular genetic aberrations cause dysfunctional growth will help elucidate the pathogenesis of this disease. Two techniques are proving useful in evaluating the clinical relevance of specific genetic aberrations in malignant gliomas. Fluorescence in situ hybridization (FISH) permits direct visualization of gains and losses of genetic material in single cells and quantitation of cellular subpopulations that have particular genetic aberrations. Comparative genomic hybridization can identify regions of genetic gain and loss in tumor DNA.

Original languageEnglish (US)
Pages (from-to)47-55
Number of pages9
JournalJournal of Neuro-Oncology
Volume24
Issue number1
DOIs
StatePublished - Feb 1995
Externally publishedYes

Fingerprint

Glioma
Cytogenetics
Comparative Genomic Hybridization
Growth
Fluorescence In Situ Hybridization
Genes
DNA
Neoplasms

Keywords

  • amplification
  • comparative genomic hybridization
  • deletion
  • fluorescence in situ hybridization
  • heterogeneity
  • malignant glioma
  • tumor genetics

ASJC Scopus subject areas

  • Neuroscience(all)
  • Oncology
  • Clinical Neurology
  • Cancer Research

Cite this

Molecular cytogenetic quantitation of gains and losses of genetic material from human gliomas. / Feuerstein, Burt G.F.; Mohapatra, Gayatry.

In: Journal of Neuro-Oncology, Vol. 24, No. 1, 02.1995, p. 47-55.

Research output: Contribution to journalArticle

@article{03ec2ffadf64424696fd7a6880d34efc,
title = "Molecular cytogenetic quantitation of gains and losses of genetic material from human gliomas",
abstract = "The unregulated growth that is characteristic of human malignant gliomas is accompanied by, and may result from, losses and/or gains of genetic material. Understanding the mechanisms that underlie how particular genetic aberrations cause dysfunctional growth will help elucidate the pathogenesis of this disease. Two techniques are proving useful in evaluating the clinical relevance of specific genetic aberrations in malignant gliomas. Fluorescence in situ hybridization (FISH) permits direct visualization of gains and losses of genetic material in single cells and quantitation of cellular subpopulations that have particular genetic aberrations. Comparative genomic hybridization can identify regions of genetic gain and loss in tumor DNA.",
keywords = "amplification, comparative genomic hybridization, deletion, fluorescence in situ hybridization, heterogeneity, malignant glioma, tumor genetics",
author = "Feuerstein, {Burt G.F.} and Gayatry Mohapatra",
year = "1995",
month = "2",
doi = "10.1007/BF01052658",
language = "English (US)",
volume = "24",
pages = "47--55",
journal = "Journal of Neuro-Oncology",
issn = "0167-594X",
publisher = "Kluwer Academic Publishers",
number = "1",

}

TY - JOUR

T1 - Molecular cytogenetic quantitation of gains and losses of genetic material from human gliomas

AU - Feuerstein, Burt G.F.

AU - Mohapatra, Gayatry

PY - 1995/2

Y1 - 1995/2

N2 - The unregulated growth that is characteristic of human malignant gliomas is accompanied by, and may result from, losses and/or gains of genetic material. Understanding the mechanisms that underlie how particular genetic aberrations cause dysfunctional growth will help elucidate the pathogenesis of this disease. Two techniques are proving useful in evaluating the clinical relevance of specific genetic aberrations in malignant gliomas. Fluorescence in situ hybridization (FISH) permits direct visualization of gains and losses of genetic material in single cells and quantitation of cellular subpopulations that have particular genetic aberrations. Comparative genomic hybridization can identify regions of genetic gain and loss in tumor DNA.

AB - The unregulated growth that is characteristic of human malignant gliomas is accompanied by, and may result from, losses and/or gains of genetic material. Understanding the mechanisms that underlie how particular genetic aberrations cause dysfunctional growth will help elucidate the pathogenesis of this disease. Two techniques are proving useful in evaluating the clinical relevance of specific genetic aberrations in malignant gliomas. Fluorescence in situ hybridization (FISH) permits direct visualization of gains and losses of genetic material in single cells and quantitation of cellular subpopulations that have particular genetic aberrations. Comparative genomic hybridization can identify regions of genetic gain and loss in tumor DNA.

KW - amplification

KW - comparative genomic hybridization

KW - deletion

KW - fluorescence in situ hybridization

KW - heterogeneity

KW - malignant glioma

KW - tumor genetics

UR - http://www.scopus.com/inward/record.url?scp=0029054187&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029054187&partnerID=8YFLogxK

U2 - 10.1007/BF01052658

DO - 10.1007/BF01052658

M3 - Article

C2 - 8523075

AN - SCOPUS:0029054187

VL - 24

SP - 47

EP - 55

JO - Journal of Neuro-Oncology

JF - Journal of Neuro-Oncology

SN - 0167-594X

IS - 1

ER -